Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

Fulgent Genetics will acquire assets from Bako Diagnostics and StrataDx for $55.5 million in a deal that will expand the company's offering of testing services.

About 1 in 10 adults aged 70 or older may be eligible for anti-amyloid therapy, finds the first population-based study to use ...

Geographic Reach: Fulgent will expand its geographic footprint with the addition of CLIA, CAP, and NY State certified laboratories in Georgia (Bako) and Massachusetts (StrataDx).

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve what makes us who we areBOSTON, December ...

The 42-year-old still faces a drug possession charge and remains under investigation following the death of a Taiwanese ...

Chandrapur: Fresh medical evidence has added a disturbing twist to the probe into multi-state kidney trafficking linked to ...

Scientists reversed advanced Alzheimer's in mice using a compound that restores cellular energy. The breakthrough challenges ...

Gut health has become a growing area of medicine and focus for several Aussie companies, with research showing links to ...

Frank has been chief of the Department of Laboratory Medicine at the National Institutes of Health Clinical Center since 2018 ...

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are across age and cognitive status in a Norwegian community cohort. Prevalence ...

Panna (Madhya Pradesh): A serious issue related to public health surfaced from Madhya Pradesh’s Panna district. According to ...